Valuation (72%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 18.92 | 7.74 |
PEG Ratio (TTM) | -0.41 | 0.28 |
P/S Ratio (TTM) | 2.13 | 2.85 |
P/B Ratio (TTM) | 1.04 | 1.61 |
P/FCF Ratio (TTM) | 10.30 | 39.72 |
Price to 5YR AVG Earnings Ratio | 4.58 | 16.14 |
Price to 5YR AVG FCF Ratio | 15.76 | 33.17 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.46% | 8.18% |
ROE (TTM) | 5.56% | 17.38% |
Net Profit Margin (TTM) | 11.56% | 30.70% |
ROIC 5YR AVG | 5.92% | 6.65% |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 297.47% | 18,884.44% | 11,322.25% |
Revenue | -25.16% | 3.76% | 0.76% |
Net Income | 258.49% | 18,634.50% | 11,167.56% |
Cash Flow | -86.19% | -301.52% | -177.83% |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.50 | 24.41 |
Quick Ratio (TTM) | 1.50 | 23.19 |
D/E Ratio (TTM) | 0.22 | 0.22 |
Interest Coverage (TTM) | 2.63 | 10.66 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 0.73 | 2.66 |
LTL to 5YR AVG FCF | 7.62 | 4.46 |
Shares Outstanding Growth 5YR AVG | -4.29% | -2.54% |